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Osteolysis due to wear-debris in cemented total hip replacement (THR) may lead to aseptic loosening, particularly in relation to the acetabular component. 1 This prompted the introduction of porous-coated uncemented devices, which had good early clinical results. 2, 3 However, initial retrieval studies following revision surgery indicated that the porous-coated surface sometimes lacked bony ingrowth. 4, 5 The decision to use a cemented or uncemented acetabular component in THR is based on a combination of factors such as surgical experience, training, patient physiology and evolving technologies. Hence a study comparing the two basic types would provide useful information.
We report the seven-year results of a prospective randomised control trial to compare a cemented all-polyethylene acetabular component (Ultima) with a cementless porous-coated cobalt-chromium acetabular component with polyethylene liner (PFC; both; Johnson & Johnson-DePuy, Leeds, United Kingdom).
Patients and Methods
Between July 1995 and July 2001, 300 candidates for primary THR with osteoarthritis or rheumatoid arthritis who were independently mobile without cognitive impairment were randomised for participation in the trial. These patients were randomised using a number generation programme with an assignment card in a sealed opaque envelope. This envelope was opened before surgery. Patients were to receive either a cemented all-polyethylene Ultima acetabular component (Group A) or a PFC porous-coated acetabular component with a polyethylene liner (Group B). If at surgery the allocated treatment method was deemed inappropriate, the patient was eligible for re-assignment to the other treatment group or exclusion from the study. Patients in both treatment groups were to receive a cemented Ultima straightstem femoral component (Johnson & Johnson) produced in titanium alloy with a 28 mm diameter cobalt-chromium head. All cementing was performed using Palacos bone cement (Heraeus Medical Ltd, Newbury, United Kingdom). Patients who underwent bilateral simultaneous THR had the right hip randomised and the left hip received the alternative acetabular component. Those who underwent staged bilateral THR had the first hip randomised and the second hip was allocated to the alternative group. The trial had ethical approval and all patients gave informed consent.
Patients aged < 55 years of age, and those judged to be unsuitable for cementless fixation at surgery at the discretion of the senior operating surgeon, were excluded.
The Ultima acetabular component is an ultra-highmolecular-weight polyethylene (UHMWPE) implant with a minimum thickness of 5 mm. It is hemispherical with a circumferential flange. The PFC acetabular component is a cobalt-chromium alloy hemispherical shell without holes, which is a porous-coated surface of cobalt-chromiummolybdenum alloy beads with a mean pore size of 290 μm and an UHMWPE liner (Fig. 1) .
All operations were performed in a laminar air-flow operating theatre. Patients received routine antibiotic prophylaxis (cefuroxime 3 doses 1.5 g + 0.75 g ×2). Anaesthetic technique was determined at the discretion of the anaesthetist. Surgical approach was either posterior or anterolateral depending on the usual practice of the operating surgeon. The prostheses were implanted following the standard operative procedure as detailed in the appropriate surgical manuals. The porous-coated cups were undersized by 2 mm and the cemented cups were sized to give a 2 mm cement mantle without pressurisation. A standardised post-operative rehabilitation protocol included immediate full weight-bearing with a frame then onto sticks with physiotherapy.
Demographic details including laterality, primary diagnosis, degree of pain (mild/moderate/severe), limp, walking capacity, true leg discrepancy and range of movement of the hip were collected on standardised forms by a dedicated orthopaedic research nurse (SB).
Functional outcome was assessed using the Harris hip score (HHS) 6 pre-and post-operatively. Patients were monitored for adverse outcomes including re-operation for any reason, infection, dislocation and medical complications such as deep-vein thrombosis, pulmonary embolism and death.
Anteroposterior pelvic and cross-table lateral radiographs of the affected hip were performed pre-operatively and at follow-up visits at six months, one year, three years and annually thereafter. Osteolysis (defined as an area of localised loss of trabecular bone or cortical erosion not apparent on the pre-operative or immediate post-operative radiographs 7 ) and radiolucent lines (defined as linear radiolucency adjacent to a sclerotic line 8 ) of 1 mm in all three DeLee and Charnley 9 zones and those > 2 mm wide in any zone were noted. Preoperative and follow-up radiographs were assessed for any migration of the acetabular component. Radiological analysis was performed by two of the authors (DSA and SB) with consensus on the reported findings. Statistical analysis. In order to include all follow-up data, whether or not they fell within a protocol defined follow-up window, the six-month follow-up window was considered to be three to nine months, and each annual follow-up window was considered to be the year minus three months to the year plus nine months. The mean HHS scores were compared using a t-test at final follow-up; mean HHS change from baseline in the two groups was compared with a t-test at six months, one, five and ten years post-operatively. Survival was estimated with KaplanMeier analysis, with 95% confidence intervals (CI); survival in the two groups was compared using the log-rank test. 10 Statistical analysis was performed using SAS software version 9.1.3 (SAS Inc., Cary, North Carolina) and statistical significance set at p < 0.05.
Results
Some patients received a different prosthesis (in some instances a non-study prosthesis) than the one to which they were randomised, either as a result of treatment reallocation or errors noted intra-operatively. All patients who received one of the two acetabular study prostheses were considered to comprise the 'as-treated' (AT) population; subjects were included regardless of protocol deviations or which device they were randomised to receive. A total of 183 patients received an Ultima acetabular component (Group A) and 104 patients received a PFC acetabular component (Group B); nine patients received a non-study device and four subjects did not have surgery (Fig. 2) . In the AT population, 16 patients (13 in Group A, three in Group B) did not have post-operative data for analysis. Of the 287 patients in the AT population who receive one of the study cups, 17 did not receive an Ultima straight stem. There were 2 revisions among these 17 patients, neither of which involved a revision of the stem. The demographics of the two groups are shown in Table I . The mean follow-up was 7.52 years (0.4 to 15.0) for patients in group A and 7.87 years (0.5 to 14.0) for those in group B.
No statistically significant difference was noted for patient or surgical characteristics including body mass index (t-test, p = 0.250), age (t-test, p = 0.087), gender (Fisher's, p = 0.322) or surgical approach (chi-squared, p = 0.060).
The mean HHS improved from 35.2 (9 to 76) and 35.7 (10 to 70) pre-operatively to 74.5 (25 to 100) and 78.0 (37 to 100) at the final follow-up in groups A and B, respectively. Patients in both groups had similar HHSs at followup visits (Fig. 3) .
There was no statistically significant difference between treatment groups in the mean HHS change from baseline at six months, one year, five years, or ten years post-operatively (Table II) .
A total of 28 patients had revision surgery, of which five did not involve revision of the acetabular prosthesis (three in Group A, two in Group B). A total of 17 patients in group A had revision surgery (revision to remove any THR component): 11 for aseptic loosening (of both components in eight, of the acetabular component only in two, and of the stem only in one), one for wear of the acetabular component, one for loosening with infection (both acetabular component and stem), three for recurrent dislocation, and one for peri-prosthetic fracture (stem only). There were 11 revisions (removal of any THR component) in group B: two for aseptic loosening (of both components in one, and of the stem only in one), one for fracture of the liner, two for loosening with infection (both components in each), one for osteolysis (stem only), three for recurrent dislocation, one for a slipped acetabular component, and one for subluxing. There was no significant difference in the rate of revision between the two groups in the 55 to 64 year age range (Fisher's, p = 1.00), in the 65 to 74 year age group (Fisher's, p = 1.00), or in the ≥ 75 year age group (Fisher's, p = 0.583) (Tables III and IV) .
The Kaplan-Meier estimate of ten-year survivorship (revision for any reason) was 86.8% (95% CI 78.4% to 92.1%) for group A (with 56 patients at risk at ten years), and 89.2% (95% CI 78.3% to 94.8%) for group B (with 36 patients at risk at ten years). The difference in survivorship between the two groups was not statistically significant (p = 0.938, log-rank) (Fig. 4) .
Of the 28 revisions, five did not involve revision of the acetabular prosthesis (three in Group A, two in Group B). The Kaplan-Meier estimate of ten-year survivorship of the acetabular component (endpoint being revision of the acetabular prosthesis) was 89.3% (95% CI 81.0% to 94.1%) for group A (with 56 patients at risk at ten years), and 92.3% (95% CI 81.9% to 96.8%) for group B (with 36 patients at risk at ten years). The difference in survivorship of the acetabular component between the two groups was not statistically significant (p = 0.961, log-rank). A total of 20 Ultima and two PFC acetabular components had evidence of radiolucencies at last follow-up; seven of these were revised for aseptic loosening (all Ultima), three were revised for loosening with infection (one Ultima, two PFC), and 12 were asymptomatic (all Ultima). There were four patients who had a revision of the acetabular component for aseptic loosening who did not have radiological evidence of loosening at last follow-up (three Ultima, one PFC). The difference in the rates of radiolucencies (20 of 183 vs 2 of 104) between the two groups was statistically significant (p = 0.001). None of the PFC components had associated expansile osteolysis.
Discussion
There have been few studies that specifically addressed acetabular fixation. In their meta-analysis Morshed et al 11 noted only five studies comparing cemented and uncemented acetabular components; all were non-randomised. Our prospective randomised study of 287 patients (as-treated) represents the largest of its kind. Graph showing the mean Harris hip scores (HHS) of the two groups pre-operatively (pre-op) and throughout the ten-year follow-up.
a matched-pair study of 45 patients, Clohisy and Harris 13 noted excellent clinical results for both types of component. We noted no significant difference between the two groups with regards to HHSs or implant survivorship at mean follow-up of 7.6 years (0.4 to 15). However in a subset of patients (≥ 75 years of age) the cemented all-polyethylene components had better survivorship (two of 66 cups revised) but this was not significant (Fisher's exact test, p = 0.583). This is similar to the results reported from the Finnish arthroplasty register.
14 Survivorship of implants is influenced by many factors ranging from materials and surface finish to surgical approach and expertise. 11 The physiology and compliance of the patient also play a crucial role. 15 The predominant mode of failure with the cemented UHMWPE components was aseptic loosening, whilst with the porous coated components a clear mode of failure was not identified (Table IV) . In this study we found no statistically significant difference between the two groups for prognostic factors including body mass index (p = 0.250), age (p = 0.087), gender (p = 0.322) and surgical approach (p = 0.060).
We found a significant difference in the radiological loosening between the cemented and porous coated cups (p = 0.001). A total of 20 of 183 (10.9%) cemented components had radiolucencies at the last follow-up and this is similar to the rate reported by others. 13, 16 Of these 20 acetabular implants, seven required revision for aseptic loosening, one required revision for loosening with infection, and the remainder were asymptomatic. The cemented acetabular components in this study were inserted without pressurisation. The significantly higher rate of radiological loosening in this group may be a reflection of this technical factor as pressurisation has been shown to be a factor affecting the radiological outcome of cemented acetabular components. 17, 18 Among the 104 cementless components, two had radiolucencies, both of which were revised for loosening/infection; there was no pelvic osteolysis, which was reported previously by Clohisy and Harris.
13
The porous-coated PFC implant used in this study has no central hole. This may explain the low rate of lucency as pelvic osteolysis has been attributed to adjunctive screw fixation. 19, 20 This is thought to be due to the screw fretting against the shell and the fact that the subsequent wear debris can then escape through the defect causing a foreign body reaction. Rates of wear of the polyethylene did not form part of our study.
When undertaking the statistical assessment we noted some patients had the alternative component inserted when, at operation, the surgeon had felt that the study component was not appropriate. This was due to a combination of patient factor (osteoporosis in elderly patients) and the surgeon considering it inappropriate to insert an uncemented component into soft bone. This resulted in slightly more cemented components being inserted but we did not feel this introduced a significant bias.
There are certain difficulties in doing a long-term prospective randomised study on a new device, such as the manufacturer modifying the design or even withdrawing the implant, as in this case. However, conclusions can still be extrapolated to subsequent designs and unless such studies are performed there can be no advancement in our knowledge. Furthermore, the long-term follow-up of patients who are elderly and may be immobile can present logistical challenges while conducting prospective studies in a district general hospital.
One criticism of randomised trials has been that the procedures are often performed on a select group of patients by small number of surgeons in specialist centres, which can make extrapolation of the results uncertain. 21 Our study was based at a district general hospital with a wide spectrum of operating surgeons such that our results may be more reflective of clinical performance across the National Health Service for similar acetabular components.
In conclusion, we found that patients with a cemented all-polyethylene acetabular component and a cementless porous-coated component with a polyethylene liner had a similar satisfactory long-term clinical outcome. Kaplan-Meier survival curves for both groups through ten years.
